SCHEMBL15214979

SCHEMBL15214979

Oc1ccc(O[C@H]2CCCO2)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HSD11B1 P28845 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
HPGD P15428 2/20 0.36
POLB P06746 1/20 0.36
TNK2 Q07912 3/20 0.36
PTPN1 P18031 1/20 0.36
TYR P14679 1/20 0.35
KDM4E B2RXH2 1/20 0.35
PCNA P12004 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15214980 1.00 ALDH1A1 (0.41) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL7155013 1.00 ALDH1A1 (0.41) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL15093959 0.95 MEN1 (0.43) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL222919 0.95 MEN1 (0.43) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL15093765 0.95 MEN1 (0.43) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL217929 0.90 TNK2 (0.43) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL15049914 0.89 HPGD (0.47) ALDH1A1HSD11B1MEN1KMT2AESR1
SCHEMBL16055037 0.87 HSD11B1 (0.41) ALDH1A1HSD11B1MEN1KMT2AHPGD
SCHEMBL21400657 0.86 APP (0.44) HSD11B1MEN1KMT2ATNK2PTPN1
SCHEMBL30279565 0.85 CALM1 (0.41) HSD11B1MEN1KMT2AESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708287-B2 Chiral compounds, compositions, products and methods employing same CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2017-07-18 US disclosed
US-9708287-B2 Chiral compounds, compositions, products and methods employing same CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2017-07-18 US disclosed
US-20160024045-A1 CHIRAL COMPOUNDS, COMPOSITIONS, PRODUCTS AND METHODS EMPLOYING SAME CAYMAN CHEMICAL COMPANY INCORPORATED 2016-01-28 US disclosed
US-9180080-B2 Chiral compounds, compositions, products and methods employing same MERZ NORTH AMERICA, INC. (US) 2015-11-10 US disclosed
US-20130224137-A1 SKIN LIGHTENING COMPOSITIONS LASYA, INC. (US) 2013-08-29 US disclosed
US-20130224136-A1 CHIRAL COMPOUNDS, COMPOSITIONS, PRODUCTS AND METHODS EMPLOYING SAME LASYA, INC. (US) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130224137-A1 SKIN LIGHTENING COMPOSITIONS CUTA, COL14A1, COLGALT1 ALDH1A1 500/4885HSD11B1 1544/4885MEN1 3556/4885
US-20160024045-A1 CHIRAL COMPOUNDS, COMPOSITIONS, PRODUCTS AND METHODS EMPLOYING SAME TYR, MITF, MC1R ALDH1A1 257/4885HSD11B1 195/4885MEN1 2828/4885
US-20130224136-A1 CHIRAL COMPOUNDS, COMPOSITIONS, PRODUCTS AND METHODS EMPLOYING SAME TYR, MITF, MC1R ALDH1A1 257/4885HSD11B1 195/4885MEN1 2828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.